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Summary
Islet β cell death precedes development of type 1 diabetes, and detecting this process may allow 
for early therapeutic intervention. Here, we provide a detailed description of how to measure 
differentially methylated INS DNA species in human serum as a biomarker of β cell death.
The death of islet β cells is thought to underlie the pathogenesis of virtually all forms of diabetes 
and to precede the development of frank hyperglycemia, especially in type 1 diabetes. The 
development of sensitive and reliable biomarkers of β cell death may allow for early therapeutic 
intervention to prevent or delay the development of diabetes. Recently, several groups including 
our own have reported that cell-free, differentially methylated DNA encoding preproinsulin (INS) 
in the circulation is correlated to β cell death in pre-type 1 diabetes and new-onset type 1 diabetes. 
Here, we present a step-by-step protocol using digital PCR for the measurement of cell-free INS 
DNA that is differentially methylated at cytosine at position -69 bp (relative to the transcriptional 
start site). We demonstrate that the assay can distinguish between methylated and unmethylated 
cytosine at position -69 bp, is linear across several orders of magnitude, provides absolute 
quantitation of DNA copy numbers, and can be applied to samples of human serum from 
individuals with new-onset type 1 diabetes and disease-free controls. The protocol described here 
can be adapted to any DNA species for which detection of differentially methylated cytosines is 
desired, whether from circulation or from isolated cells and tissues, and can provide absolute 
quantitation of DNA fragments.
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Introduction
Type 1 diabetes (T1D) is an autoimmune disease that is characterized by the destruction of 
insulin-producing islet β cells by autoreactive T cells1. The diagnosis of T1D is typically 
made upon measurement of hyperglycemia (blood glucose > 200 mg/dl) in a lean, young 
individual, who might present with ketoacidosis as evidence of insulin deficiency. At the 
time of diagnosis of T1D, there is evidence for substantial loss of β cell function and mass 
(from 50 – 90%)2. In clinical studies, several immune modulatory drugs that were instituted 
at the time of diagnosis resulted in the stabilization of β cell function (and presumably 
mass), but none have resulted in clinical remission of disease, a finding that has raised the 
call for the development of biomarkers for earlier detection of the disease and for the 
longitudinal tracking of effectiveness of combination therapies3,4. Efforts by international 
consortia, such as the Human Islet Research Network Consortium at the National Institutes 
of Heath5, have emphasized the need to develop biomarkers that focus on β cell stress and 
death in T1D.
In line with these efforts, our group and others have recently developed biomarker assays 
that measure circulating, epigenetically modified DNA fragments that arise primarily from 
dying β cells6–9. In all of the published assays to date, the focus has been on the quantitation 
of the human gene encoding preproinsulin (INS), which demonstrates greater degrees of 
unmethylated CpG sites in the coding and promoter regions compared to other cell types. 
The liberation of unmethylated INS DNA fragments was hypothesized as arising primarily 
from dying (necrotic, apoptotic) β cells. Our recent studies showed that in youth, elevations 
in both unmethylated and methylated INS DNA at position -69 bp (relative to the 
transcriptional start site) were observed in new-onset T1D, and together served as specific 
biomarkers for this population6. These biomarker assays involve the isolation of cell-free 
DNA from serum or plasma using commercial spin kits, followed by a bisulfite conversion 
of the isolated DNA (to convert non-methylated cytosines to uracils, leaving methylated 
cytosines intact).
In this report, we describe the technical aspects of serum sample collection, isolation of cell-
free DNA from serum, bisulfite conversion, and performance of droplet digital PCR 
(henceforth, digital PCR) for differentially methylated INS DNA.
Protocol
Ethics Statement: Protocols were approved by the Indiana University Institutional Review 
Board. Parents of subjects provided written informed consent, and children older than 7 
years provided assent for their participation.
1. Serum Processing
NOTE: The assay as described has been rigorously tested using human serum isolated as 
follows.
1. Collect blood in one red top (no-additive; uncoated) blood collection tube.
2. Let sit at room temperature for 30 min to allow the clot to form.
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3. Centrifuge tube at 2,000 × g for 10 min at room temperature. Transfer the 
supernatant (serum) to a new tube designated for serum storage (polypropylene 
screw top tubes, size dependent on samples).
4. Store samples at −80 °C until ready for DNA isolation.
2. Serum DNA Extraction
NOTE: DNA is extracted with a DNA extraction kit using 50 μl of serum (recommended), 
following manufacturer’s protocol with some modifications.
1. Prepare 200 μl lysis buffer + 1 μl poly(A) (5 μg) per sample in an 
microcentrifuge tube. Vortex for 15 sec. Set aside until Step 2.3.
2. Take serum samples from −80 °C freezer and thaw at room temperature. Bring 
serum sample volume up to 200 μl total using phosphate-buffered saline (PBS, 
with calcium chloride and magnesium chloride).
3. Lyse the sample by adding 20 μl protease (1.4 Anson units/ml) to sample, 
followed by 200 μl lysis buffer/polyA mix (from Step 2.2) and vortex for 8 sec. 
Incubate sample at 56 °C for 10 min, then briefly centrifuge for 7 sec at top 
speed in a microcentrifuge (>10,000 × g).
4. Precipitate DNA by adding 230 μl 100% ethanol to sample and vortex for 8 sec. 
Briefly centrifuge for 7 sec at top speed (>10,000 × g).
5. Apply the DNA to the spin column by adding 600 μl sample mixture to mini spin 
column. Centrifuge at 6,000 × g for 1 min. Discard the flow-through and place 
column in a clean tube.
6. Wash the DNA by adding 500 μl wash buffer 1 to the column. Centrifuge at 
6,000 × g for 1 min. Discard the flow-through and place column in a clean tube. 
Add 500 μl wash buffer 2 to column and centrifuge at top speed (>10,000 × g) 
for 3 min. Place column in a new 1.5 ml microcentrifuge tube and centrifuge at 
top speed again for 1 min.
7. Elute the DNA by placing column in a new 1.5 ml microcentrifuge tube and 
adding 60 μl elution buffer directly on the filter. It is important to switch tips 
between samples to prevent cross contamination. Incubate at room temperature 
for 5 min, then centrifuge at 6,000 × g for 1 min. Add another 60 μl of elution 
buffer and centrifuge at 6,000 × g for 1 min.
8. Store DNA at −20 °C for later use, or proceed immediately to bisulfite 
conversion.
3. Bisulfite Conversion
NOTE: Bisulfite conversion is performed using a bisulfite conversion kit, following the 
manufacturer’s protocol with some modifications.
1. To convert unmethylated cytosines to uracils, add 130 μl of bisulfite conversion 
reagent to 20 μl of DNA from step 2.7 in a PCR tube (single 0.2 ml PCR tube or 
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8-strip PCR tubes). Save the remaining 40 μl of DNA for future use, or use in 
replicate reactions. Mix 20 times by pipetting up and down and centrifuge briefly 
to make sure no drops are on sides or lid. Incubate in a water bath or thermal 
cycler as follows: 98 °C for 8 min, 54 °C for 60 min, 4 °C for 5 min.
1. Proceed to step 3.2 or store at 4 °C for up to 20 hr.
2. Add 600 μl of binding buffer to spin column and place the column in the 
provided collection tube. Apply the bisulfited DNA to column and mix by 
pipetting up and down 10 times. Centrifuge at top speed (>10,000 × g) for 30 
sec. Discard flow-through.
3. Wash DNA by adding 100 μl of wash buffer to column and centrifuge at top 
speed (>10,000 × g) for 30 sec.
4. Perform desulphonation to remove sulphonate group to finalize the conversion of 
unmethylated cytosines to uracil by adding 200 μl of desulphonation buffer to the 
column. Let stand at room temperature for 20 min, then centrifuge at top speed 
(>10,000 × g) for 30 sec.
5. Wash DNA by adding 200 μl of wash buffer to the column and centrifuge at full 
speed for 30 sec. Discard the flow-through and repeat this wash step.
6. Place the column into a 1.5 ml microcentrifuge tube. Elute DNA by adding 10 μl 
elution buffer directly to column filter. Incubate for 1 min. Centrifuge for 30 s at 
full speed to elute DNA. Quantify recovered DNA by spectrophotometry at 
A260.
NOTE: The DNA detected by spectrophotometry represents primarily the carrier 
polyA DNA that was added at step 2.3 above. Typically, recovery of polyA is 
≥85% of the input (>4.25 μg).
7. Store DNA at −20 °C until ready to proceed with digital PCR.
4. Multiplex Digital PCR
1. Make a master mix with enough solution for each sample and control. Include at 
least one sample containing water (negative control), one sample of a plasmid 
containing unmethylated INS (1 pg, positive control), one sample of plasmid 
containing methylated INS (1 pg, positive control), and one sample containing a 
1:1 mixture of plasmids.
1. To prepare the PCR master mix, add 12.5 μl per reaction of PCR buffer (e.g., 125 
μl per 10 samples), 1.25 μl per reaction primer/probe mix (e.g., 12.5 μl per 10 
samples), 8.25 μl per reaction water (e.g., 82.5 μl per 10 samples), 0.5 μl per 
reaction EcoR1 enzyme (e.g., 5 μl per 10 samples).
NOTE: Primers and probes used here are as follows: Forward Primer: 5′-
GGAAATTGTAGTTTTAGTTTTTAGTTATTTGT-3′; Reverse Primer: 5′-
AAAACCCATCTCCCCTACCTATCA-3′; FAM probe: FAM-5′-
ACCCCTACCACCTAAC-3′-MGB; VIC probe: VIC-5′-
ACCCCTACCGCCTAAC-3′-MGB.
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2. Set up multiplex PCR reaction in a 96-well plate Add 19.5 μl of master mix to 
each well. Add 2.5 μl of bisulfite converted DNA sample into each appropriate 
well (save the remaining 7.5 μl of bisulfite converted DNA or use in replicate 
reactions). Mix by pipetting up and down several times.
NOTE: All 8 wells in a row must contain sample or buffer control.
3. Seal with a foil seal using a plate sealer and centrifuge in a plate spinner until 
there is no liquid on the sides of the wells.
4. Set up the automated droplet generator on the touchscreen.
NOTE: All 8 wells in the cartridge must contain sample or buffer control.
1 Set the number of rows being used by touching the row(s) in which samples are 
loaded into on the 96-well plate from step 4.2 and highlight the row in blue to 
indicate an active row.
2 Load consumables from back to front to avoid contamination. To start, add 
cartridges along the back row of the instrument. Load tips into center row of the 
instrument.
NOTE: The cartridges can only fit into the holders in the correct orientation.
3 Place 96-well plate into the instrument. Remove a cold block from −20 °C 
freezer and place a new skirted 96-well plate into it. Place it inside the 
instrument next to the sample loaded 96-well plate.
4 Add oil to dispenser in the front of the instrument. Select type of oil on 
touchscreen.
5 Touch the blue start button to start the run. Confirm plate setup and touch start 
run button to begin.
5 Once finished, remove the 96-well plate that contains the newly formed droplets 
and seal with a foil seal using a plate sealer.
6 Perform PCR10 on a thermal cycler using the following program: 95 °C for 
10:00 min; 40 cycles at: 94 °C for 00:30 min, 57.5 °C for 01:00 min; 98 °C for 
10:00 min; 12 °C for 10 min or up to 24 hr.
7 Place the plate on the droplet reader and set up the reader.
1. Click on the setup tab. Open a new template by clicking template > new. Enter a 
file name.
2. Use the well editor to set the parameters for each sample. Give each sample a 
unique name, set experiment to Rare Event Detection (R-RED), and set master 
mix to the mix used in step 4.1.
3. Give Target 1 a name (i.e., unmethylated) and set Target 1 as unknown (U). Give 
Target 2 a name (i.e., methylated) and set Target 2 as reference (R).
4. Click Run tab to start the run. In the run options window, select the detection 
chemistry (FAM/VIC).
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5. Data Analysis
1. Open results in analyze tab and analyze using 2-D plot based on positive controls 
(see Figure 1).
2. Export CSV file generated by droplet reader to a spreadsheet program for data 
analysis.
3. To generate “copies per μl” of serum, use the formula: (concentration*250)/
(volume of serum used for DNA isolation in μl).6
NOTE: The data is typically converted to log10 when acquired from human 
serum to ensure normal distribution. Alternatively, data can be plotted on a log10 
scale and analyzed by non-parametric statistics.
Representative Results
To interpret data appropriately, we use plasmid controls for both the unmethylated and 
methylated target INS DNA in each digital PCR run. These controls ensure that signals 
corresponding to methylated and unmethylated DNA are clearly distinguishable. Figure 1 
shows the 2-D scatter plots corresponding to droplets for plasmid controls containing 
bisulfite-converted unmethylated INS DNA (Figure 1A), methylated INS DNA (Figure 1B), 
and a 1:1 mixture of the two plasmids (Figure 1C). Plasmid containing unmethylated INS is 
indicated by the droplets positive for the 6-Carboxyfluorescein (FAM) signal, whereas 
plasmid containing methylated INS is indicated by the droplets positive for the VIC signal. 
In the 1:1 plasmid mixture, a population of double-positive droplets is seen, corresponding 
to droplets containing both species of DNA. To distinguish positive droplets from negative 
droplets, data are gated using these 2-D plots. Note that in Figure 1A, there is a slight shift 
of the FAM-positive droplets into the VIC channel, indicating that the probe for the 
methylated INS DNA exhibits some cross-reactivity for the unmethylated INS DNA. 
Similarly, in Figure 1B, there is a very slight shift of the VIC-positive droplets into the FAM 
channel, indicating cross-reactivity of the probe for the unmethylated DNA with methylated 
DNA. A major advantage of digital PCR is it can still discriminate specific signals even 
when probes are not 100% specific. For appropriate Poisson statistical calculations by the 
software, each PCR reaction should partition into at least 10,000 total droplets, display a 
cluster of negative droplets, and show a clear amplitude difference between negative and 
positive droplets (for reliable gating). To demonstrate linearity of our primers, we performed 
mixtures of the two plasmids across several orders of magnitude. As shown in Figure 2, 
varying concentrations of one plasmid can be linearly detected in the presence of a constant 
amount of the second plasmid. For new labs performing this procedure, we recommend 
constructing a similar mixture experiment to ensure that the assay is operating in a linear 
detection fashion.
Next, we obtained serum of three subjects with new-onset T1D (within 2 days of diagnosis) 
and three control individuals without T1D (see Table 1 for clinical characteristics). Protocols 
were approved by the Indiana University Institutional Review Board. Parents of subjects 
provided written informed consent. Figure 3 shows the quantitation of unmethylated and 
methylated INS DNA copy numbers/μl serum, converted to log10 from these controls and 
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T1D subjects. The data show that individuals with T1D exhibit elevated levels of both 
methylated and unmethylated INS DNA compared to controls, similar to data reported 
previously6.
Discussion
Methylation of cytosines by DNA methyltransferases allows for the epigenetic control of 
transcription at many genes. The INS gene in humans is almost exclusively expressed in islet 
β cells, and there appears to be a correlation between the frequency of methylation of 
cytosines in the INS gene to silencing of its transcription11. As such, most cell types show 
substantially higher frequencies of methylation of the INS gene at various cytosines 
compared to β cells11–13. It has been proposed that the prevalence of β cell death could be 
monitored by analysis of the serum levels of cell-free unmethylated INS DNA, which would 
arise largely from dying β cells that liberate their DNA12.
The bisulfite reaction converts unmethylated cytosines into uracils, leaving methylated 
cytosines unchanged14. Sequencing or PCR analysis of bisulfite-converted DNA therefore 
allows determination of whether the original cytosine was methylated or not. Methylation-
specific PCR using dye-based technology exploits differences in PCR efficiency owing to 3′ 
base-pair mismatches between primers and template, and thereby allows distinction of 
unmethylated vs. methylated cytosines following bisulfite conversion of DNA15. 
Accordingly, dye-based PCR was used to quantitate the relative ratio of unmethylated to 
methylated INS in early studies of T1D subjects12,16. However, dye-based PCR technology 
has several drawbacks, including limited specificity, lack of absolute quantitation of DNA 
fragment concentrations, and the inability to multiplex (i.e., detect both methylated and 
unmethylated DNA species in the same reaction). Other groups have performed direct 
sequencing of cell-free DNA fragments, a technique that allows monitoring of several 
differentially methylated CpG sites with much greater specificity9. However, the sequencing 
technique requires large sample volumes, is not easily amenable to use of banked samples, 
and is expensive.
As a result of these limitations, our group and others have employed digital PCR, a 
technique that provides absolute quantitation of DNA fragments, requires only microliter 
quantities of serum from fresh or banked samples, is amenable to multiplexing, shows 
greater sensitivity than traditional quantitative PCR, and is less expensive than direct 
sequencing. Digital PCR technology involves the use of conventional primer/probe assays 
and a microfluidics-based partitioning of a water-in-oil PCR reaction into ~ 20,000 droplets. 
Following thermal cycling of the partitioned reaction, the droplets are subsequently analyzed 
by a flow cytometer to identify droplets with positive and negative signals. Poisson statistics 
is used to calculate absolute quantities (copy numbers) of each DNA species. The conceptual 
details of digital PCR have been described elsewhere17.
This protocol describes the measurement of β cell death in humans by measuring 
differentially methylated INS DNA by digital PCR. Our data presented here and elsewhere6 
show that primer/probe combinations that detect differential methylation of cytosine at 
position -69 (relative to the transcriptional start site of INS) exhibit sufficient specificity for 
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either the unmethylated cytosine (FAM probe) or the methylated cytosine (VIC probe) (see 
Figure 1A and B). Mixtures of plasmids containing both methylated and unmethylated INS 
fragments at position -69 bp (i.e., bisulfite-converted DNA having either uracil or cytosine at 
position -69 bp) exhibit droplets containing one or the other plasmid, or both plasmids 
(double-positive signals in Figure 1C). The Poisson statistical calculation utilizes the droplet 
numbers that are positive for a given probe (whether single-positive or double-positive) to 
derive the copy numbers of each methylated or unmethylated DNA fragment.
When utilizing human serum for the measurement of differentially methylated cytosines at 
position -69 bp in cell-free DNA (Figure 3), our data demonstrate two key features: (1) 
levels of methylated INS are 5–10-fold higher in these subjects than unmethylated INS 
(regardless of diagnosis), and (2) absolute levels of both unmethylated and methylated INS 
are higher in subjects with new-onset T1D compared to controls. Whereas the higher levels 
of methylated INS compared to unmethylated INS likely reflect the greater burden of cell-
free DNA emanating from non-β cells, the higher levels of both species of INS in new-onset 
T1D subjects likely reflects both an increase in prevalent β cell death (unmethylated INS), 
and possibly death/turnover of other cell types that are associated with the disease state (e.g., 
innate and adaptive immune cells). Further speculation on the elevations of both species of 
INS in new-onset T1D subjects was discussed previously6. Regardless of the sources of both 
species of INS in serum from these individuals, it is notable that measurement of ratios of 
unmethylated to methylated INS (as reported by other investigators using dye-based PCR) 
would not have picked up the significant differences in absolute levels described here and in 
our recent publication6, thus emphasizing the power of digital PCR for this type of 
biomarker analysis.
Some precautions and limitations should be noted. We feel it is important that blood is 
processed within 4 hr of collection and either used immediately for DNA isolation or stored 
at −80 °C for future use. In unpublished studies, we have observed some loss of DNA 
recovery after 4 hr of collection, perhaps owing to DNA degradation, as seen in studies of 
long-term storage of samples18. Because of the increased sensitivity of digital PCR, special 
care should be taken to avoid contamination of samples that would otherwise not be 
noticeable in traditional qPCR Finally, a key limitation of the technique is the analysis of 
samples in which droplet generation does not exceed ~10,000 droplets. Such samples do not 
provide reliable Poisson statistics, and as such may be considered uninterpretable. Multiple 
causes of such low droplet generation might include technical errors in sample handling, 
technical issues with the droplet generator, or issues related to quality of reagents used.
In summary, this report describes the detailed protocol for measurement of differentially 
methylated, cell-free INS DNA at position -69 bp by digital PCR. The protocol described 
here can be adapted to any DNA species for which detection of differentially methylated 
cytosines is desired, whether from circulation or from isolated cells and tissues, and can 
provide absolute quantitation of DNA fragments.
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Materials
Name Company Catalog Number Comments
Red Top Vacutainer Beckon Dickinson 366441 no additive, uncoated 
interior, 10 ml
Cryovial Tube Simport T310-3A polypropylene, screw 
cap tube, any size
QIAamp DNA Blood Mini Kit Qiagen 51106
Poly(A) Sigma P9403 disloved in TE buffer 
(10 mM Tris-Cl pH 
8.0 + 1 mM EDTA) to 
5 μg/μl
Absolute Ethanol (200 Proof) Fisher Scientific BP2818-500
DPBS (with CaCl2 and MgCl2) Sigma D8662
0.2 ml PCR 8-strip Tubes MidSci AVST
8-strip Caps, Dome MidSci AVSTC-N
EZ DNA Methylation-Lightning Kit Zymo D5031
ddPCR Supermix for Probes (No dUTP) Biorad 1863024
Buffer Control for Probes Biorad 1863052
Human Unmethylated/Methylated Primer/Probe 
mix
Life Technologies AH21BH1
EcoR1 New England Biolabs R0101L
twin.tec PCR Plate 96, semi-skirted Eppendorf 951020346
Pierceable Foil Heat Seal Biorad 1814040
PX1 PCR Plate Sealer Biorad 1814000
QX200 AutoDG Droplet Digital PCR System Biorad 1864101
Automated Droplet Generation Oil for Probes Biorad 186-4110
DG32 Cartridge for Automated Droplet 
Generator
Biorad 186-4108
Pipet Tips for Automated Droplet Generator Biorad 186-4120
Pipet Tip Bins for Automated Droplet 
Generator
Biorad 186-4125
C1000 Touch Thermal Cycler Biorad 1851197
QX200 Droplet Reader Biorad 186-4003
ddPCR Droplet Reader Oil Biorad 186-3004
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Figure 1. Representative 2-D Plots of Plasmid Controls
Plasmid standards were generated by cloning fragments of bisulfite-converted INS DNA 
harboring unmethylated or methylated cytosine at position -69 bp relative to the INS 
transcriptional start site. Shown are 2-D plots using plasmid containing unmethylated (A) 
and methylated (B) INS DNA and for a 1:1 mixture of the two plasmids (C). Arrows identify 
the unmethylated, methylated, and unmethylated + methylated (double-positive) INS DNA-
containing droplets. FAM = Target 1; VIC = Target 2. Please click here to view a larger 
version of this figure.
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Figure 2. Quantitation of DNA Targets using Control Plasmid Mixtures
Plasmid standards containing cloned fragments of bisulfite-converted INS DNA harboring 
unmethylated or methylated cytosine at position -69 bp relative to the INS transcriptional 
start site were mixed at the various combinations shown, then subjected to multiplex digital 
PCR. The figure shows the quantitation of target DNA fragments, presented as copies/μl; r2 
= 0.989 for unmethylated INS DNA and r2 = 0.998 for methylated INS DNA. Please click 
here to view a larger version of this figure.
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Figure 3. Circulating Unmethylated and Methylated INS DNA Levels in Controls and Subjects 
with T1D
Serum samples were collected from 4 youth with new-onset T1D and from 4 disease-free, 
unrelated controls, then processed for measurement of differentially methylated INS DNA 
by digital PCR. Shown are results of digital PCR assays for unmethylated (A) and 
methylated (B) INS DNA. Data is displayed as individual points and mean ± SEM. Statistics 
were analyzed by a two-tailed parametric Students t test. Please click here to view a larger 
version of this figure.
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Table 1
Demographics of Controls and Subjects with T1D.
Controls T1D at onset
Age (years) 10.3 ± 1.3 9.2 ± 1.0
Female/Male 1:3 1:3
BMI Z-Score 0.30 ± 0.9 0.74 ± 0.9
HbA1C (%) 11.1 ± 0.6
C-Peptide (pmol/L) 285.5 ± 37.0
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